Oregon Bio is pleased to offer programming to support the bioscience industry and our member companies. Below are highlighted signature events that we have offered in the past. For upcoming events, please visit our Upcoming Events page.
Day at the Capitol
April 27, 2017 at Oregon State Capitol, Salem, Oregon
On April 27, Oregon’s leading biotechnology and life science companies converged in Salem at the Oregon Capitol to bring innovation and advocacy front and center with our state’s lawmakers.
Legislators and their staffs, as well as dozens from the industry were able to connect among the many companies that brought demonstrations of their products and technologies. Firms came from around the state including Nemametrix and ThermoFisher from Eugene; Valliscor from Corvallis (see their tweet below); and Patheon and Lonza (formerly Capsugel/Bend Research) from Bend. Portland metro area organizations included DesignMedix, Elex Biotech, Jupiter Devices, Oregon Bioscience Incubator/OTRADI, Oregon Health & Science University, Recentia Health, UbiVac and Welch Allyn.
— Rich G. Carter (@richgcarter_OSU) April 27, 2017
Also showcasing its new proposed biotechnology-focused building, Summit Development Group shared architectural renderings to spread the word about the new wet labs, development space and creative offices soon to be realized in Portland’s Innovation Quadrant at 808 S.E. Alder Street.
The outreach to state legislators was well timed and integrated with several pieces of proposed legislation that may have significant impacts on the industry. Following the morning session at the Capitol, Oregon Bio hosted the 21st Century Cures event at the Salem Convention Center.
Beyond the Microscope: Examining Policies to Grow the Life Sciences Industry in Oregon
August 11, 2015 at The Nines Hotel, Portland, Oregon
At this important summit led by industry leaders from Portland, Bend and Corvallis, we reviewed policies to support and cultivate the life sciences sector in Oregon. More information about the three panel discussions are below. Read more about Oregon Bio Policy or check out our infographic about the bioscience sector.
Translating Research to Industry
- Moderator: Erin Flynn, Ph.D., PSU
- Brendan Rauw, OHSU
- Karl Mundorff, OSU Advantage Accelerator
- Shula Jaron, Ph.D., FertiLab Thinkubator
- Linda Hansen, Ph.D., Providence Health & Services
Growing Bioscience Companies in Oregon
- Moderator: Ryan Dunlap, MolecularMD
- Bernard Fox, Ph.D., UbiVac
- Andrew Barofsky, RevMedx
- Lisa Dzubay, Grace Bio-Labs
- Matt Beaudet, NemaMetrix
Sustaining and Expanding Bioscience Companies in Oregon
- Moderator: Jennifer Fox, Ph.D., OTRADI
- Matt Smits, Biotronik/MSEI
- Ken Betschart, Genentech
- Kyle Gee, ThermoFisher Scientific
- Soundharya Nagasubramanian, Welch Allyn
Oregon Bio 2015: Expanding the Ecosystem
September 9-10, 2015 in Portland, Oregon
As Oregonians we are rightly proud of our quality of life, however, our bioscience ecosystem has been a work in progress. In the areas of manufacturing supply chain, educated workforce, and research and development, Oregon has been traditionally strong. Now it is time to leverage our current industry momentum to make permanent and lasting improvements to this bioscience ecosystem.
Oregon Bio 2015 highlighted the innovative perspectives of nationally respected researchers, innovators and investors while highlighting the opportunities found in Oregon’s research and entrepreneurial sectors. To compete with the world’s best entrepreneurial ecosystems, Oregon must learn to cultivate innovation and reward the risks these pioneers take. Read more about Oregon Bio 2015.
Oregon Bio 2013: The Economics of Life Sciences
September 16-18, 2013 at Marylhurst University, Marylhurst, Oregon
Once again, Oregon’s bioscience community gathered to learn from national experts how to adapt to the trends driving the economics of our industry. This unique two- day conference exposed attendees to the strategies, resources and experts executives need to successfully navigate our rapidly changing industry. Read more about Oregon Bio 2013.
Seeking 21st Century Cures
April 27, 2017 at Salem Convention Center, Salem, Oregon
Crucial conversations are underway across the country and world in board rooms, classrooms, universities, labs and researcher meetings in efforts to capture the myriad benefits and capitalize on the opportunities afforded by the 21st Century Cures Act. The ‘Cures’ Act, signed into law in December 2016, is designed to accelerate the discovery, development, and delivery of present and future cures and authorizes $6.3 billion in funding, mostly for the National Institutes of Health.
Following the Day at the Capitol, Carol Pratt Ph.D., J.D., Partner and Regulatory Attorney with Lee & Hayes, presented at Oregon Bio’s 21st Century Cures in Oregon event, explaining how the Act will impact the practice and research around precision medicine. She particularly focused on the ongoing collaborations among federal agencies, the import and facilitation of Big Data and the new regulatory and legal requirements of how new policies will be needed to secure and protect data.
Bryce Olson, cancer patient and Global Marketing Director of Health and Life Sciences at Intel keynoted the event, detailing his personal health journey and how he pushed his oncologist to sequence his genes to obtain entry in a targeted clinical trial that had amazing results. Bryce proudly wears a t-shirt that proclaims, “Sequence Me!”
Chris Edwards, Assistant Vice President for Strategic Initiatives at the University of Oregon, also spoke at the event sharing his work on how the new $500 million contribution by Nike’s founder to the university has culminated in the $1 billion fundraising efforts for the Phil and Penny Knight Campus for Accelerating Scientific Impact.
With over 100 participants, the event spurred active conversations and networking at the following Bio in the Valley event. Thanks to sponsors of the 21 Century Cures event, Biotechnology Innovation Organization and Genentech, for their generous support.
Oregon Bio 2016: The Bioscience Landscape
October 20-21, 2016 at Reed College, Portland, Oregon
From a panel of futurists to rockstar entrepreneurs and scientists, Oregon Bio welcomed more than 300 attendees to its signature annual conference. The Company Pitch Showcase and Research Fast Pitch, both held on the first day of the conference, highlighted exciting startups and research scientists from Oregon. Attendees were also able to visit research posters presented by Oregon State University students and delve into the range of professional development and translational research/tech transfer topics during breakout sessions. Day one ended with an awards ceremony and jam session with blues band, Holfar Blue.
The second day of the conference highlighted innovation and collaboration with other sectors, from innovation strategy at Columbia Sportswear to the future of precision medicine at Intel Life Sciences. Attendees also heard from expert speakers on diversity topics, including generational differences and unconscious bias, and on developing bioscience throughout Oregon. Throughout the day, 26 exhibitors from Oregon and throughout the U.S. interacted and networked with conference attendees. The second day of Oregon Bio programming closed with a keynote highlighting bioscience legislation and remarks and Q&A with U.S. Senator, Ron Wyden. Read more about Oregon Bio 2016.
Strategy Briefing: Bioscience Innovation and Economic Impact in Oregon
May 3, 2015 at OMSI, Portland, Oregon
The new economic impact study shows bioscience in Oregon generates high-paying jobs, while bringing new money to the state through domestic and international exports. In 2014, the direct economic activity associated with Oregon’s bioscience industry includes:
- 17,874 jobs and $1.3 billion in total wages,
- An average annual wage of $74,188, which is 62 percent greater than the statewide average wage for private sector employment,
- $3.8 billion in exports, and
- $171.5 million in state and local taxes paid by bioscience firms and their employees.
- Congresswoman Suzanne Bonamici (D – 1st District)
- Congressman Kurt Schrader (D – 5th District)
- Gary Locke, Fmr. U.S. Ambassador to China, U.S. Secretary of Commerce and Washington State Governor
- Denise McCarty, Executive Director, Oregon Bio
- Andrew Barofsky, CEO/President, RevMedx
Oregon Bio 2014: An Industry Inflection Point
September 15-17, 2014 at Marylhurst University, Marylhurst, Oregon
Oregon has long been a strong regional center of life science activity. The momentum and international attention of the $1 Billion OHSU Knight Cancer Challenge has created a “transformative moment” that will dramatically impact bioscience in the state – potentially enhancing commercialization opportunities, increasing resources available for research activity and elevating the visibility of all stakeholders working to solidify Oregon’s growing reputation as a hub for advanced medical research and commercialization.
Oregon Bio 2014 showcased the efforts of entrepreneurs and researchers responding to this opportunity in ways that reveal a growing statewide capacity and competency that is often invisible to those outside the industry. Conference speakers profiled academic, policy and industry driven initiatives that have successfully supported innovation and job creation. Oregon Bio 2014 celebrated the recent achievements throughout our state, explored opportunities that inspire life sciences professionals and offered potential solutions to the capital formation and professional/workforce training challenges our industry faces. Read more about Oregon Bio 2014.